Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate

Journal of Rheumatology

Volumn 21, Issue 1, 1994, Pages 44-50

  Yasuda, M ^a   Sakai, K ^a   Oribe, M ^a   Yoshioka, K ^a   Takahashi, H ^a   Ohtsuka, E ^a   Wada, T ^a   Shiokawa, S ^a   Yamamoto, M ^a   Ichibangase, Y ^a   Motomatsu, T ^a   Komemushi, S ^a   Nobunaga, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

additive DMARD therapy; bucillamine; disease modifying antirheumatic drugs; double blind controlled study; rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; BUCILLAMINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FEVER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER TOXICITY; MALE; NAUSEA; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RHEUMATOID ARTHRITIS; VERTIGO;

AGED; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CHILD, PRESCHOOL; CYSTEINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GOLD SODIUM THIOMALATE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028125655     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)